[
  {
    "ts": null,
    "headline": "Boston Scientific Corp. stock underperforms Monday when compared to competitors",
    "summary": "Boston Scientific Corp. stock underperforms Monday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=1a6c0090636705df3b400c978f2078980b2067836f0cd5beffee32f08a372c77",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757954160,
      "headline": "Boston Scientific Corp. stock underperforms Monday when compared to competitors",
      "id": 136777273,
      "image": "",
      "related": "BSX",
      "source": "MarketWatch",
      "summary": "Boston Scientific Corp. stock underperforms Monday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=1a6c0090636705df3b400c978f2078980b2067836f0cd5beffee32f08a372c77"
    }
  },
  {
    "ts": null,
    "headline": "Is Boston Scientific (BSX) Outperforming Other Medical Stocks This Year?",
    "summary": "Here is how Boston Scientific (BSX) and Akero Therapeutics, Inc. (AKRO) have performed compared to their sector so far this year.",
    "url": "https://finnhub.io/api/news?id=e419a7b59f07b7f249c8fdfbd83c27cd6f94e0f96b75f0c0647b5279f7ac63e5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757947202,
      "headline": "Is Boston Scientific (BSX) Outperforming Other Medical Stocks This Year?",
      "id": 136765990,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Here is how Boston Scientific (BSX) and Akero Therapeutics, Inc. (AKRO) have performed compared to their sector so far this year.",
      "url": "https://finnhub.io/api/news?id=e419a7b59f07b7f249c8fdfbd83c27cd6f94e0f96b75f0c0647b5279f7ac63e5"
    }
  },
  {
    "ts": null,
    "headline": "Oppenheimer Touts Boston Scientific Corporation (BSX) as the Best Large-Cap MedTech",
    "summary": "Boston Scientific Corporation (NYSE:BSX) is one of the best defensive stocks to buy, according to Steve Cohen. On September 8, analysts at Oppenheimer upgraded the stock to an ‘Outperform’ from Perform and reiterated a $125 price target. The upgrade comes as Oppenheimer views the company as one of the best large-cap MedTech growth stories owing […]",
    "url": "https://finnhub.io/api/news?id=72b387c2150716e7f15ad427531b2c62e5a74d76a133d8feb48b09e59ddb82eb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757945010,
      "headline": "Oppenheimer Touts Boston Scientific Corporation (BSX) as the Best Large-Cap MedTech",
      "id": 136749637,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific Corporation (NYSE:BSX) is one of the best defensive stocks to buy, according to Steve Cohen. On September 8, analysts at Oppenheimer upgraded the stock to an ‘Outperform’ from Perform and reiterated a $125 price target. The upgrade comes as Oppenheimer views the company as one of the best large-cap MedTech growth stories owing […]",
      "url": "https://finnhub.io/api/news?id=72b387c2150716e7f15ad427531b2c62e5a74d76a133d8feb48b09e59ddb82eb"
    }
  }
]